Mandar S. Jog, MD, FRCPC, is the Director of the Parkinson Disease and Movement Disorders Program at London Health Sciences Centre and a Professor of Neurology at Western University, both in London, Ontario, Canada. He also is a Professor of Computer and Electrical Engineering.
He trained in Neurology in Toronto and completed a fellowship in movement disorders with Dr. Anthony Lang. This was followed by a 4-year post-doctoral fellowship in Computational Neuroscience at the Massachusetts Institute of Technology (MIT) in Boston, Massachusetts, under Dr. Ann Graybiel and a visiting professorship at Stanford Research Institute (SRI Inc.) in California.
Dr. Simuni leads a comprehensive movement disorders center at Northwestern University Feinberg School of Medicine that is recognized by the Parkinson’s Foundation, Huntington Disease Society of America and Wilson’s Foundation as a Center of Excellence and serves as a training model in the region.
She is internationally recognized expert in design and implementation of PD clinical trials focused on disease modification. She is the lead author of the new biological definition and staging framework of Neuronal Synuclein disease (NSD). She serves on the leadership team of the MJFF sponsored PPMI study, the largest PD biomarker initiative where she also serves as the Principal Investigator for the first platform trial to test therapeutics in biologically defined prodromal population (P2P). She serves on a number of Steering Committees for the PD international clinical trials, several committees of the Parkinson Study Group and the Parkinson Foundation.